Today: 9 June 2026
Browse Category

LSE:CRH 21 November 2025 - 30 December 2025

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH shares fell 1.1% to $126.01 in New York Tuesday after the company disclosed buying 31,100 shares Monday under its U.S. buyback program. The repurchases, part of a $300 million plan, came as markets traded in thin year-end conditions. Investors awaited Federal Reserve minutes due later in the day. Other U.S.-listed aggregates producers also slipped.
30 December 2025
·
CRH PLC Stock Week Ahead: S&P 500 Inclusion, New Acquisition, Buyback Signals and Analyst Targets for Dec. 22–26, 2025

CRH PLC Stock Week Ahead: S&P 500 Inclusion, New Acquisition, Buyback Signals and Analyst Targets for Dec. 22–26, 2025

CRH plc will join the S&P 500 before markets open Monday, following its primary NYSE listing in 2023. The company announced the acquisition of North American Aggregates to expand in New York and New Jersey. CRH closed at $124.42 Friday after a volatile session. Analysts remain bullish, but debate how much of the recent rally is due to index inclusion versus earnings strength.
21 December 2025
··
Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Saga plc jumped 8.36% to 317.50p on Monday, leading UK gainers after Kernow Asset Management predicted a 400% upside for the stock. Kainos Group rose 6.65%, Empire Metals added 5.98%, PayPoint gained 5.13%, and CRH advanced 4.88%. The FTSE 100 closed subdued as rising gilt yields and a weaker pound weighed on the broader market.
9 December 2025
······
CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH will join the S&P 500 on December 22, the company confirmed Monday. Its New York-listed shares surged in pre-market trading, jumping from $119.65 to about $128 after the announcement. London shares also hit a new 12-month high, reaching 9,602p. S&P Dow Jones Indices said CRH will replace LKQ in the quarterly rebalance.
8 December 2025
···
Carvana, CRH and Comfort Systems USA Join the S&P 500: What the December 2025 Rebalance Means for Investors

Carvana, CRH and Comfort Systems USA Join the S&P 500: What the December 2025 Rebalance Means for Investors

S&P Dow Jones Indices will add Carvana, CRH, and Comfort Systems USA to the S&P 500, effective December 22, 2025. LKQ Corp., Solstice Advanced Materials, and Mohawk Industries will be removed and shifted to the S&P SmallCap 600. All three new S&P 500 entrants surged in after-hours trading, while the outgoing stocks slipped. The changes follow the index committee’s quarterly rebalance.
6 December 2025
····
Ireland Stocks Today: ISEQ Edges Higher Near Record as Banks Lead, State Exits AIB; Ryanair Profit Boom Lifts Sentiment

Ireland Stock Market Today, 21 November 2025: ISEQ Slips Below 12,000 as Banks Weigh, Kerry and CRH Stand Out

Ireland’s ISEQ All-Share index closed at about 11,992 on Friday, down 0.26% amid a global tech sell-off and renewed interest rate concerns. Bank of Ireland and AIB shares slipped, while Kerry Group outperformed. The index lost 1.4% for the week. Investors weighed the Finance Bill 2025 and CRH’s ex-dividend date against a backdrop of broad market declines.
21 November 2025
·····

Stock Market Today

  • Redwire Shares Fall After $500 Million At-The-Market Stock Offering Announcement
    June 9, 2026, 10:33 AM EDT. Redwire Corp shares dropped 6.5% after the company filed a $500 million at-the-market (ATM) stock program with the U.S. SEC. The ATM program allows Redwire to sell shares gradually at prevailing prices, providing flexible capital raising but risking shareholder dilution. The stock slide comes despite strong underlying demand, with CEO Peter Cannito citing a $498 million backlog and a 57.9% revenue jump in Q1. Redwire's $3.37 billion market cap contrasts with its ongoing net losses, and CEO reaffirmed 2026 revenue guidance of $450-$500 million. The stock decline was specific to Redwire following its financing news, while other space sector peers advanced.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop